Explant surgery, the removal of breast implants, is a procedure for those experiencing complications or concerns related to their implants or those who simply want to remove breast implants to avoid the symptoms of BII and gain peace of mind. Dr. Shaher Khan, a specialist in Breast Implant Illness (BII), emphasizes the importance of thorough pathology testing during explant procedures. This testing is a cornerstone of what is known as “The Khan Procedure,” ensuring that patients receive comprehensive care and peace of mind during their recovery.
The Necessity of Pathology Testing
Pathology testing is a meticulous examination of the tissues and fluids removed during explant surgery. It is crucial to identify any underlying issues that may not be apparent during the surgery itself. Dr. Khan mandates the pathology of capsules or any abnormal tissue, along with microbiology for culture testing and cytology if any fluid is present. This ensures that no stone is left unturned to ensure optimal patient health and safety.
The Scope of Pathology Testing
Capsule and Tissue Analysis
During explant surgery, the capsule – the scar tissue that naturally forms around the implant – and any additional tissue are sent for detailed analysis. This examination looks for any signs of cancer, abnormal cells, inflammation, and foreign materials such as silicone and polyurethane. These findings are critical to direct post-operative care and future medical monitoring.
Fluid Analysis and Lymphoma Screening
Any fluids extracted during the procedure are tested for CD30, a protein associated with lymphoma cells, particularly in Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). A positive CD30 test necessitates further examination for anaplastic lymphoma kinase (ALK), although lymphoma cells related to BIA-ALCL typically test negative for this protein. This step is vital for early detection and treatment of potential lymphoma.
Microbiology and Culture Testing
Microbiology tests are conducted to detect the presence of bacteria and fungi. These tests are essential for identifying infections that may not have produced symptoms but could cause complications if left untreated. The specialist may also perform a cytology, which examines a single cell type if any fluid is found.
The Khan Procedure: A Comprehensive Approach
Dr. Khan’s approach to explant surgery is holistic and patient-centered. Every surgery is documented through photos and videos, providing patients with a visual record of the procedure. This transparency is a cornerstone of The Khan Procedure.
Antibiotics and Postoperative Care
Depending on individual circumstances, Dr. Khan may advise taking antibiotics post-explant surgery to prevent infections. This recommendation is part of a comprehensive care plan tailored to ensure the patient’s health and recovery.
The visual documentation of the surgery serves multiple purposes. It acts as an educational tool for the patient, a record for future medical reference, and a testament to the meticulous care and integrity of the surgical process.
Implant and Capsule Handling
Dr. Khan ensures that all patients have their implants returned to them post-explant. This practice is not universally adopted, but it is a testament to Dr. Khan’s commitment to patient autonomy and involvement in their healthcare decisions.
The Importance of Post-Explant Analysis
Following explant surgery, the analysis of removed materials is not merely a procedural formality; it is a critical step in ensuring patient health. The findings from pathology tests can guide the necessary follow-up care and provide peace of mind to patients who have undergone the stress of implant-related complications.
Pathology testing during explant surgery is an indispensable part of the explant process, especially within The Khan Procedure. Dr. Shaher Khan’s dedication to thorough testing, patient education, and transparency sets a high standard for care in explant surgery. Please consult Dr. Khan to explore your breast explant surgery options.